T1	Participants 254 346	43 patients with carcinoma of the cervix uteri, all of whom were treated by radical surgery.
T2	Participants 347 452	All patients had carcinoma confined to the cervix, the upper part of the vagina or the parametrial region
T3	Participants 454 559	When the malignancy had spread to the parametrial region, additional postoperative radiotherapy was given
T4	Participants 561 692	22 patients received immunotherapy 10 days before surgery, whereas the remaining 21 control patients received no immune stimulation
